Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc. scores highest on Torque (46) and lowest on Price (1). Its PosiPenta is 18.59 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, Delta-Fly Pharma, Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,056 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Delta-Fly Pharma, Inc. | 18.59 | 1 | 36 | 2 | 46 | 9 |
| PhoenixBio Co., Ltd. | 32.06 | 44 | 28 | 13 | 39 | 36 |
| Recovery International Co.,Ltd. | 50.73 | 43 | 61 | 48 | 67 | 34 |
| Wel-Dish.Incorporated | 44.34 | 99 | 38 | 1 | 58 | 25 |
| GIMIC Co., Ltd. | 50.57 | 80 | 58 | 12 | 72 | 31 |
| Kohjin Bio Co., Ltd. | 34.55 | 54 | 39 | 9 | 36 | 36 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.51 |
| P/B ratio | 30.14 |
EEarnings
| Trailing EPS | ₹-85.02 |
| Forward EPS | ₹-11.20 |
NNitro
| Price | 43.59 |
| 52-week high | 423.76 |
| 52-week low | 41.16 |
| Fall from 52-week high | 89.7% |
TTorque
| Return on equity (ROE) | -736.84% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -0.78 |
| Market cap | ₹62 Cr |
| Insider holding | 11.52% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Delta-Fly Pharma, Inc.'s PosiPenta score?
Delta-Fly Pharma, Inc.'s PosiPenta is 18.59 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Delta-Fly Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Delta-Fly Pharma, Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,056 of 1,059 in Japan.
Which PosiPenta pillar is strongest for Delta-Fly Pharma, Inc.?
Torque (durability), with a score of 46 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Delta-Fly Pharma, Inc.?
Price (valuation), with a score of 1 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.